Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy.
about
Drug discovery in ophthalmology: past success, present challenges, and future opportunitiesDoes autoimmunity against thyroglobulin play a role in the pathogenesis of Graves' ophthalmopathy: a reviewGraves' ophthalmopathyIncreased generation of fibrocytes in thyroid-associated ophthalmopathy.Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathyPhenothiourea sensitizes zebrafish cranial neural crest and extraocular muscle development to changes in retinoic acid and IGF signalingTeprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes.Disturbances of modulating molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA expressions in the orbital tissue from patients with severe graves' ophthalmopathyBidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves' disease immunoglobinsOrbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNAIncreased response to oxidative stress challenge in Graves' ophthalmopathy orbital fibroblasts.TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist.Graves' ophthalmopathy: a review of immunogenetics.Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production.Effects of sequential injections of hepatocyte growth factor and insulin-like growth factor-I on adult rabbit extraocular muscle.TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB.The protective effect of antioxidants on orbital fibroblasts from patients with Graves' ophthalmopathy in response to oxidative stress.Advances in the management of thyroid eye diseaseRole of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.Inhibiting thyrotropin/insulin-like growth factor 1 receptor crosstalk to treat Graves' ophthalmopathy: studies in orbital fibroblasts in vitro.The effect of orbital radiation therapy on thyroid-associated orbitopathy complicated with dysthyroid optic neuropathy.Increased oxidative DNA damage, lipid peroxidation, and reactive oxygen species in cultured orbital fibroblasts from patients with Graves' ophthalmopathy: evidence that oxidative stress has a role in this disorder.TSH/IGF-1 Receptor Cross-Talk Rapidly Activates Extracellular Signal-Regulated Kinases in Multiple Cell Types.Does rituximab improve clinical outcomes of patients with thyroid-associated ophthalmopathy? A systematic review and meta-analysis.Efficacy and safety of mycophenolate mofetil in patients with active moderate-to-severe Graves' orbitopathy.Sinonasal abnormalities in patients with Graves' orbitopathy.
P2860
Q26771638-D34A0724-2A74-4674-BED8-18E0BEFC3E4FQ26776335-6FED525A-92E3-4755-A0E6-4B70C05F7775Q28274196-AADCC33A-8724-420E-8B61-36B06C4BCB14Q33586738-9E1EA991-8D13-4601-AF00-A9317D1F707BQ33624477-BBC07C54-B8A4-452D-81CC-4ABB3394B45CQ34008775-E1331BC0-3A8D-4033-AB39-BACC024159F5Q34130987-29DED5EB-AB1D-436C-881E-6B207D8FB220Q35012933-476320B8-E921-4DFC-8E24-044250D23985Q35096870-9CDB31F4-C464-4874-AEC2-729C3FE1C717Q35153361-032263B5-EEB7-441C-8864-AAF3EFA42539Q35531750-CEF32638-CBE7-4FB2-A671-F97AF911F77DQ35667567-ECCD5F89-4CDA-46A1-9C13-7F20614B2DC0Q35731002-CEE96953-6087-47E6-9E91-CD3AC89E82FEQ35921354-85C4D97B-76A7-4952-BF2F-21C06160A62FQ36201302-940CB341-DFA7-4A32-9965-8DCC7796C02BQ36393011-E35B758F-7BC0-408C-8C47-824BBA86D503Q36422528-EB3DA82F-BA1A-456C-9227-631F7C41F85EQ36846603-AF2F2EF5-6D86-4962-A133-172E1B103A6BQ37012076-C4AD04B7-7BE7-4602-9380-353F1F1606BAQ37017174-A0C1D956-A728-420E-A4E5-358BAD4A5282Q39093117-C8A715CB-7E43-4991-A5C1-1D197FFF6D19Q39303459-2311FA46-B6D3-4495-94FB-54D4C1F2AD64Q43124440-960450A0-F0C0-4F7F-A71F-D7AB0DA1D4E5Q47761035-34286291-B0B3-48E4-BC2D-2938D74236F5Q49920960-EC6ADE08-4D32-4BA0-94F0-C46286099DCBQ53057871-7472BFA1-AF31-40D2-8435-52FEE0C9FCEDQ53242653-F44AB83C-EDCC-4BFC-849E-26236E7C158C
P2860
Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Unique attributes of orbital f ...... oid-associated ophthalmopathy.
@en
type
label
Unique attributes of orbital f ...... oid-associated ophthalmopathy.
@en
prefLabel
Unique attributes of orbital f ...... oid-associated ophthalmopathy.
@en
P2093
P2860
P50
P356
P1433
P1476
Unique attributes of orbital f ...... roid-associated ophthalmopathy
@en
P2093
Andrew G Gianoukakis
Beiling Chen
Chieh Chih Tsai
Chris Press
Chris S King
Mei-Ju Shih
Richard P Phipps
Robert A Goldberg
Shanli Tsui
P2860
P304
P356
10.1089/THY.2007.0404
P577
2008-09-01T00:00:00Z